Top Penny Stocks To Watch In May 2025

Simply Wall St.
15小时前

As the U.S. stock market experiences a positive streak, with the Dow Jones and S&P 500 rising for the eighth consecutive day, investors are keenly observing how major tech earnings influence broader economic sentiment. Penny stocks, though often overlooked due to their historical connotations, remain relevant as potential investment opportunities in this dynamic landscape. These stocks typically represent smaller or newer companies and can offer unexpected growth potential when supported by strong financial fundamentals. In this article, we explore several penny stocks that may stand out for their financial robustness and long-term promise.

Top 10 Penny Stocks In The United States

Name Share Price Market Cap Financial Health Rating
Safe Bulkers (NYSE:SB) $3.39 $354.37M ★★★★☆☆
Tuya (NYSE:TUYA) $2.35 $1.19B ★★★★★★
Smith Micro Software (NasdaqCM:SMSI) $0.9894 $17.95M ★★★★☆☆
Kiora Pharmaceuticals (NasdaqCM:KPRX) $3.30 $9.9M ★★★★★★
Flexible Solutions International (NYSEAM:FSI) $3.77 $49.07M ★★★★★★
Waterdrop (NYSE:WDH) $1.31 $481.01M ★★★★★☆
TETRA Technologies (NYSE:TTI) $2.85 $367.28M ★★★★☆☆
BAB (OTCPK:BABB) $0.819475 $5.97M ★★★★★★
Lifetime Brands (NasdaqGS:LCUT) $3.625 $81.25M ★★★★★☆
CBAK Energy Technology (NasdaqCM:CBAT) $0.785 $72.17M ★★★★★☆

Click here to see the full list of 754 stocks from our US Penny Stocks screener.

Let's explore several standout options from the results in the screener.

KORU Medical Systems

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions for the drug delivery market both in the United States and internationally, with a market cap of $126.38 million.

Operations: The company generates revenue of $33.65 million from its Surgical & Medical Equipment segment.

Market Cap: $126.38M

KORU Medical Systems, with a market cap of US$126.38 million, is navigating the penny stock landscape by focusing on strategic growth and financial stability despite current unprofitability. The company reported a net loss reduction to US$6.07 million for 2024 from US$13.74 million the previous year, signaling improved cost management. Recent developments include an extended credit facility with HSBC Ventures USA and an agreement with a global pharmaceutical firm to develop advanced infusion systems, potentially enhancing future revenue streams. KORU's experienced management and board support its strategic initiatives while maintaining sufficient cash runway for over three years.

  • Dive into the specifics of KORU Medical Systems here with our thorough balance sheet health report.
  • Assess KORU Medical Systems' future earnings estimates with our detailed growth reports.
NasdaqCM:KRMD Financial Position Analysis as at May 2025

Metalpha Technology Holding

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Metalpha Technology Holding Limited, along with its subsidiaries, offers wealth management services in Hong Kong and has a market cap of approximately $69.47 million.

Operations: The company generates revenue of $31.40 million from trading proprietary digital assets and derivative contracts.

Market Cap: $69.47M

Metalpha Technology Holding, with a market cap of US$69.47 million, has shown significant progress in the penny stock arena by becoming profitable this year, reporting a net income of US$6.04 million for the half-year ended September 2024. The company's revenue surged to US$19.72 million from US$5.09 million year-over-year, driven by trading proprietary digital assets and derivative contracts. Despite its volatile share price and an inexperienced management team, Metalpha remains debt-free with strong short-term asset coverage over liabilities and a high return on equity at 24.6%. Recent board changes include appointing CFO Pengyuan Fan as director following Ming Ni's resignation.

  • Get an in-depth perspective on Metalpha Technology Holding's performance by reading our balance sheet health report here.
  • Review our historical performance report to gain insights into Metalpha Technology Holding's track record.
NasdaqCM:MATH Revenue & Expenses Breakdown as at May 2025

Applied Energetics

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Applied Energetics, Inc. specializes in the development and sale of advanced lasers, optical systems, and guided energy solutions for various sectors including defense and industrial markets, with a market cap of approximately $149.28 million.

Operations: The company's revenue is primarily derived from its Aerospace & Defense segment, totaling $2.43 million.

Market Cap: $149.28M

Applied Energetics, Inc., with a market cap of US$149.28 million, faces challenges typical of penny stocks, including a net loss of US$9.17 million for 2024 and an auditor's going concern doubt. Despite these hurdles, the company is advancing its strategic collaboration with Kord Technologies to develop an advanced pulsed laser system at its Tucson Battle Lab, potentially opening new defense market opportunities. Recent private placements have provided additional capital following insufficient cash runway projections based on free cash flow estimates. Though unprofitable and lacking significant revenue growth, Applied Energetics has improved its shareholder equity over five years.

  • Navigate through the intricacies of Applied Energetics with our comprehensive balance sheet health report here.
  • Gain insights into Applied Energetics' past trends and performance with our report on the company's historical track record.
OTCPK:AERG Revenue & Expenses Breakdown as at May 2025

Next Steps

  • Unlock our comprehensive list of 754 US Penny Stocks by clicking here.
  • Seeking Other Investments? Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NasdaqCM:KRMD NasdaqCM:MATH and OTCPK:AERG.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10